Madam Speaker, the study of universal pharmacare by the Standing Committee on Health is ongoing. It heard from dozens of witnesses—patient advocates and experts in medicine, social policy, constitutional law, pharmaceutical manufacturing, insurance—and the committee asked the PBO to prepare a report, giving certain parameters to guide the committee in the evaluation of policy options. It is premature to call upon the government to do anything. We want to give Canadians a better plan and cost it. The committee is working hard and knows this is essential. We all know Canadians need better pharmacare. That is why we are working hard on that.
In the House of Commons on October 5th, 2017. See this statement in context.